The New York Times, ABC News and Fortune recently quoted NACDS on the issue, underscoring its message that inaction at this pivotal time could set the nation back, leave the nation less prepared and cost the nation more lives.
Tlando is an oral treatment for testosterone replacement therapy indicated for conditions associated with a deficiency or absence of endogenous testosterone or hypogonadism in adult males.
The FDA authorized a second booster dose in adults aged 50 years old and older and for those aged 12 years old and older with compromised immune systems.